Patient Education PDF on Key Decisions in HIV Care: Start Now With Rapid ART

Download this PDF to share with your patients newly diagnosed with HIV who are considering rapid initiation of ART.
person default
Jason Schafer, PharmD, MPH
Format: Adobe Acrobat (.pdf)
File Size: 238 KB
Released: February 28, 2022

Acknowledgements

Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Information on this Educational Activity

Faculty

Jason Schafer, PharmD, MPH

Professor and Vice Chair
Jefferson College of Pharmacy
Thomas Jefferson University
Philadelphia, Pennsylvania

Jason Schafer, PharmD, MPH, has disclosed that he has received consulting fees from Merck, Viiv, and Theratechnologies and funds for research support from Gilead and Merck.

Program Medium

This program has been made available online.

Related Content

Dr Kenric Ware discusses how technology and social media can impact PrEP adherence and persistence, from Clinical Care Options (CCO)

person default Kenric Ware, PharmD, AAHIVP Released: January 23, 2023

Dr Kenric Ware discusses considerations for ongoing PrEP candidacy and persistence, from Clinical Care Options (CCO)

person default Kenric Ware, PharmD, AAHIVP Released: January 20, 2023

Slides on HIV ART management in complex clinical situations, including extensive previous treatment, from Clinical Care Options (CCO)

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Released: January 11, 2023

In this case-based video module, Dr Jill Blumenthal shares key data and recommendations about PrEP in transgender young adults, from Clinical Care Options (CCO)

Jill Blumenthal, MD, MAS Released: January 9, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings